PHAT logo

Phathom Pharmaceuticals, Inc. (PHAT) Net income

annual net income:

-$334.33M-$132.73M(-65.84%)
December 31, 2024

Summary

  • As of today (September 16, 2025), PHAT annual net profit is -$334.33 million, with the most recent change of -$132.73 million (-65.84%) on December 31, 2024.
  • During the last 3 years, PHAT annual net income has fallen by -$190.44 million (-132.36%).
  • PHAT annual net income is now -25856.99% below its all-time high of -$1.29 million, reached on December 31, 2018.

Performance

PHAT Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPHATincome statement metrics

quarterly net income:

-$75.81M+$18.51M(+19.62%)
June 30, 2025

Summary

  • As of today (September 16, 2025), PHAT quarterly net profit is -$75.81 million, with the most recent change of +$18.51 million (+19.62%) on June 30, 2025.
  • Over the past year, PHAT quarterly net income has increased by +$15.64 million (+17.10%).
  • PHAT quarterly net income is now -26041.38% below its all-time high of -$290.00 thousand, reached on September 30, 2018.

Performance

PHAT quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPHATincome statement metrics

TTM net income:

-$330.15M+$15.64M(+4.52%)
June 30, 2025

Summary

  • As of today (September 16, 2025), PHAT TTM net profit is -$330.15 million, with the most recent change of +$15.64 million (+4.52%) on June 30, 2025.
  • Over the past year, PHAT TTM net income has dropped by -$33.04 million (-11.12%).
  • PHAT TTM net income is now -113746.21% below its all-time high of -$290.00 thousand, reached on September 30, 2018.

Performance

PHAT TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPHATincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

PHAT Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-65.8%+17.1%-11.1%
3 y3 years-132.4%-48.9%-101.2%
5 y5 years-31.0%-259.3%-59.2%

PHAT Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-132.4%at low-100.5%+19.6%-101.2%+4.5%
5 y5-year-159.0%at low-259.3%+19.6%-155.8%+4.5%
alltimeall time<-9999.0%at low<-9999.0%+22.6%<-9999.0%+4.5%

PHAT Net income History

DateAnnualQuarterlyTTM
Jun 2025
-
-$75.81M(-19.6%)
-$330.15M(-4.5%)
Mar 2025
-
-$94.32M(+26.7%)
-$345.79M(+3.4%)
Dec 2024
-$334.33M(+65.8%)
-$74.45M(-13.0%)
-$334.33M(-1.5%)
Sep 2024
-
-$85.58M(-6.4%)
-$339.44M(+14.2%)
Jun 2024
-
-$91.45M(+10.4%)
-$297.11M(+20.5%)
Mar 2024
-
-$82.85M(+4.1%)
-$246.63M(+22.3%)
Dec 2023
-$201.59M(+2.0%)
-$79.57M(+84.0%)
-$201.59M(+13.8%)
Sep 2023
-
-$43.24M(+5.6%)
-$177.07M(-4.2%)
Jun 2023
-
-$40.97M(+8.3%)
-$184.92M(-5.1%)
Mar 2023
-
-$37.81M(-31.3%)
-$194.87M(-1.4%)
Dec 2022
-$197.72M
-$55.05M(+7.7%)
-$197.72M(+10.8%)
Sep 2022
-
-$51.09M(+0.3%)
-$178.50M(+8.8%)
Jun 2022
-
-$50.92M(+25.2%)
-$164.07M(+9.6%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$40.66M(+13.5%)
-$149.71M(+4.0%)
Dec 2021
-$143.88M(+11.5%)
-$35.83M(-2.3%)
-$143.88M(-11.1%)
Sep 2021
-
-$36.66M(+0.3%)
-$161.78M(+1.6%)
Jun 2021
-
-$36.55M(+4.9%)
-$159.22M(+10.7%)
Mar 2021
-
-$34.84M(-35.1%)
-$143.77M(+11.4%)
Dec 2020
-$129.07M(-49.4%)
-$53.72M(+57.5%)
-$129.07M(-25.5%)
Sep 2020
-
-$34.10M(+61.6%)
-$173.35M(-16.4%)
Jun 2020
-
-$21.10M(+4.8%)
-$207.36M(+11.3%)
Mar 2020
-
-$20.14M(-79.4%)
-$186.26M(+12.1%)
Dec 2019
-$255.13M(>+9900.0%)
-$98.01M(+43.9%)
-$166.12M(+143.9%)
Sep 2019
-
-$68.11M(>+9900.0%)
-$68.11M(>+9900.0%)
Dec 2018
-$1.29M
-
-
Sep 2018
-
-$290.00K
-$290.00K

FAQ

  • What is Phathom Pharmaceuticals, Inc. annual net profit?
  • What is the all time high annual net income for Phathom Pharmaceuticals, Inc.?
  • What is Phathom Pharmaceuticals, Inc. annual net income year-on-year change?
  • What is Phathom Pharmaceuticals, Inc. quarterly net profit?
  • What is the all time high quarterly net income for Phathom Pharmaceuticals, Inc.?
  • What is Phathom Pharmaceuticals, Inc. quarterly net income year-on-year change?
  • What is Phathom Pharmaceuticals, Inc. TTM net profit?
  • What is the all time high TTM net income for Phathom Pharmaceuticals, Inc.?
  • What is Phathom Pharmaceuticals, Inc. TTM net income year-on-year change?

What is Phathom Pharmaceuticals, Inc. annual net profit?

The current annual net income of PHAT is -$334.33M

What is the all time high annual net income for Phathom Pharmaceuticals, Inc.?

Phathom Pharmaceuticals, Inc. all-time high annual net profit is -$1.29M

What is Phathom Pharmaceuticals, Inc. annual net income year-on-year change?

Over the past year, PHAT annual net profit has changed by -$132.73M (-65.84%)

What is Phathom Pharmaceuticals, Inc. quarterly net profit?

The current quarterly net income of PHAT is -$75.81M

What is the all time high quarterly net income for Phathom Pharmaceuticals, Inc.?

Phathom Pharmaceuticals, Inc. all-time high quarterly net profit is -$290.00K

What is Phathom Pharmaceuticals, Inc. quarterly net income year-on-year change?

Over the past year, PHAT quarterly net profit has changed by +$15.64M (+17.10%)

What is Phathom Pharmaceuticals, Inc. TTM net profit?

The current TTM net income of PHAT is -$330.15M

What is the all time high TTM net income for Phathom Pharmaceuticals, Inc.?

Phathom Pharmaceuticals, Inc. all-time high TTM net profit is -$290.00K

What is Phathom Pharmaceuticals, Inc. TTM net income year-on-year change?

Over the past year, PHAT TTM net profit has changed by -$33.04M (-11.12%)
On this page